stars 1 stars 2 stars 3

Elasmogen is a therapeutic biologics company developing dual targeting products for difficult-to-treat immune-mediated diseases. Our lead, first-in-class product, ELN28, is designed to target to the site of inflammation where it neutralises soluble TNFa whilst specifically and safely delivering Janus kinase inhibitor. Our mission is to clinically advance ELN28, positioning it as a truly transformative therapy for Hidradenitis Suppurativa.

Website http://www.elasmogen.com
Revenue $5.8 million
Employees 11 (7 on RocketReach)
Founded 2016
Address Elasmogen Ltd Liberty Building Foresterhill Health Campus, Aberdeen, Aberdeen City AB25 2ZP, GB
Technologies
Industry Biotechnology Research, Business Services General, Medical, Therapeutic biologics, Business Services, Health Care, Autoimmune and Inflammatory disease, Therapeutics
Web Rank 19 Million
Keywords Elasmogen, Ccab
Competitors Aquinox Pharmaceuticals, Inc., Amgen, Lilly India, Roche, Genentech, Bristol Myers Squibb, AstraZeneca, Regeneron, Zynerba Pharmaceuticals, Moderna Therapeutics +43 more (view full list)
SIC SIC Code 873 Companies, SIC Code 87 Companies
NAICS NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 541714 Companies

Elasmogen Ltd Questions

The Elasmogen Ltd annual revenue was $5.8 million in 2026.

Robert Boyd is the VP R and D of Elasmogen Ltd.

7 people are employed at Elasmogen Ltd.

Elasmogen Ltd is based in Aberdeen, Aberdeen City.

The NAICS codes for Elasmogen Ltd are [5417, 54, 54171, 541, 541714].

The SIC codes for Elasmogen Ltd are [873, 87].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users